top of page
The latest from NuvOx
Search
DDFPe as a Resuscitation Fluid for Hemorrhagic Shock and Traumatic Brain Injury: A Review
Animal studies, for both hemorrhagic shock and TBI, show promising effects of DDFPe as a resuscitation fluid.
Nov 8, 2017
NuvOx Wins TechConnect Defense Innovation Award
NuvOx was awarded the TechConnect Defense Innovation Award based on the potential impact the technology will have on national security.
Oct 18, 2017
NuvOx Pharma wins AZBio Fast Lane Award
NuvOx was honored with the AZBIO Fast Lane Award for the company's many achievements in the last 18 months.
Oct 11, 2017
National Cancer Institute Grants $3M to NuvOx Pharma for Phase II Clinical Trial in Brain Cancer
The NCI Grants $3M to NuvOx for a Phase II clinical trial in the brain cancer, glioblastoma.
Sep 29, 2017
DDFPe reduced secondary brain injury in a Swine Model of Traumatic Brain Injury
In this swine model of TBI, administration of DDFPe resulted in lower injury scores for
spongiosis and ischemic neurons.
Jul 11, 2017
bottom of page